Tech Company Financing Transactions
Ritter Pharmaceuticals Funding Round
Ritter Pharmaceuticals closed a $3.7 million funding round on 12/31/2014. Backers included Javelin Venture Partners.
Transaction Overview
Company Name
Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$3,694,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1880 Century Park East 1000
Los Angeles, CA 90067
USA
Los Angeles, CA 90067
USA
Phone
Email Address
Overview
Ritter (NASDAQ: RTTR) is committed to the discovery, development and commercialization of novel therapeutic treatments for gastrointestinal diseases and conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Ritter
VP - Bus. Development
Ira Ritter
VP - Finance
John Beck
Browse more venture capital transactions:
Prev: 12/31/2014: Arsia Therapeutics venture capital transaction
Next: 12/31/2014: Exablox venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs